Nasacort and Nasonex are both allergy nasal sprays that contain drugs called corticosteroids. With allergies, the body’s immune system responds to an allergen, or trigger. This causes symptoms such as ...
Last week, on Friday, June 15, 2012, Merck (NYSE: MRK) announced the U.S. District Court for the District of New Jersey (Judge Peter G. Sheridan) ruled against the company on the issue of patent ...
June 15 (Reuters) - Merck & Co, Inc lost a patent infringement lawsuit against Apotex Inc on Friday over Apotex's plans to market a generic version of the nasal allergy spray Nasonex. Sign up here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback